{"nct_id":"NCT02286219","title":"Phase 1, Multiple Ascending Dose Study of Anti-HER2 FCAB FS102 in HER2 Positive Solid Tumors (Anti HER2 Fcab)","status":"COMPLETED","status_verified_date":"2017-09","start_date":"2014-11-04","start_date_type":"ACTUAL","primary_completion_date":"2017-06-08","primary_completion_date_type":"ACTUAL","completion_date":"2017-06-08","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["BMY"]}